Search details
1.
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2.
Drug Resist Updat
; 71: 101011, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37865067
2.
The origin of regulatory from the effector cells in LAG-3-marked Th1 immunity against severe influenza virus infection.
Immunology
; 169(2): 167-184, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36522294
3.
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.
Int J Mol Sci
; 24(18)2023 Sep 12.
Article
in English
| MEDLINE | ID: mdl-37762275
4.
Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat.
Int J Mol Sci
; 22(5)2021 Mar 05.
Article
in English
| MEDLINE | ID: mdl-33807514
5.
Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.
J Nat Prod
; 83(5): 1461-1472, 2020 05 22.
Article
in English
| MEDLINE | ID: mdl-32347726
6.
Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.
Mol Pharm
; 16(7): 3040-3052, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-31117741
7.
The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Int J Mol Sci
; 21(1)2019 Dec 29.
Article
in English
| MEDLINE | ID: mdl-31905792
8.
Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter.
Mol Pharm
; 14(8): 2805-2814, 2017 08 07.
Article
in English
| MEDLINE | ID: mdl-28641010
9.
Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells.
Mol Pharm
; 14(7): 2368-2377, 2017 07 03.
Article
in English
| MEDLINE | ID: mdl-28597653
10.
Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro.
Mol Pharm
; 13(6): 2117-25, 2016 06 06.
Article
in English
| MEDLINE | ID: mdl-27169328
11.
Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase.
Mol Pharm
; 13(3): 784-94, 2016 Mar 07.
Article
in English
| MEDLINE | ID: mdl-26796063
12.
Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.
J Nat Prod
; 79(8): 2135-42, 2016 08 26.
Article
in English
| MEDLINE | ID: mdl-27504669
13.
Human ATP-Binding Cassette Transporter ABCB1 Confers Resistance to Volasertib (BI 6727), a Selective Inhibitor of Polo-like Kinase 1.
Mol Pharm
; 12(11): 3885-95, 2015 Nov 02.
Article
in English
| MEDLINE | ID: mdl-26412161
14.
Overexpression of human ABCB1 in cancer cells leads to reduced activity of GSK461364, a specific inhibitor of polo-like kinase 1.
Mol Pharm
; 11(10): 3727-36, 2014 Oct 06.
Article
in English
| MEDLINE | ID: mdl-25192198
15.
Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.
ACS Pharmacol Transl Sci
; 7(1): 161-175, 2024 Jan 12.
Article
in English
| MEDLINE | ID: mdl-38230272
16.
An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza.
Commun Biol
; 6(1): 600, 2023 06 03.
Article
in English
| MEDLINE | ID: mdl-37270623
17.
Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV.
Front Immunol
; 14: 1204314, 2023.
Article
in English
| MEDLINE | ID: mdl-37731482
18.
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.
Biochem Pharmacol
; 188: 114516, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33713643
19.
Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.
Front Cell Dev Biol
; 9: 699571, 2021.
Article
in English
| MEDLINE | ID: mdl-34350184
20.
MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs.
Am J Cancer Res
; 10(1): 164-178, 2020.
Article
in English
| MEDLINE | ID: mdl-32064159